share_log

Oppenheimer Initiates Coverage On Inari Medical With Outperform Rating, Announces Price Target of $75

Oppenheimer Initiates Coverage On Inari Medical With Outperform Rating, Announces Price Target of $75

奧ppenheimer對Inari Medical發起覆蓋,給予超出市場表現評級,並宣佈目標價爲75美元。
Benzinga ·  03:38  · 評級/大行評級

Oppenheimer analyst Steve Lichtman initiates coverage on Inari Medical (NASDAQ:NARI) with a Outperform rating and announces Price Target of $75.

奧本海默分析師史蒂夫·利希特曼以跑贏大盤的評級啓動了對Inari Medical(納斯達克股票代碼:NARI)的報道,並宣佈目標股價爲75美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論